Cases & Deals

  • Home
  • Practices
  • Funds managed by Invesco Asset Management Limited participate in $27 million Series C financing round of Vedanta Biosciences

Share

Funds managed by Invesco Asset Management Limited participate in $27 million Series C financing round of Vedanta Biosciences

December 2018

Clients Invesco Asset Management Limited

Jones Day advised funds managed by Invesco Asset Management Limited in connection with their participation in the $27 million Series C financing round of Vedanta Biosciences, Inc., a clinical-stage company developing therapies for immune-mediated diseases based on human microbiome-derived bacteria.

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.